BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7738389)

  • 41. Treatment of alopecia areata with squaric acid dibutylester.
    Caserio RJ
    Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modified immunotherapy for alopecia areata.
    Yoshimasu T; Furukawa F
    Autoimmun Rev; 2016 Jul; 15(7):664-7. PubMed ID: 26932732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical immunotherapy in alopecia areata.
    Happle R
    J Invest Dermatol; 1991 May; 96(5):71S-72S. PubMed ID: 2022878
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnosis and therapy of alopecia areata].
    Happle R
    Z Hautkr; 1990 Dec; 65(12):1096-100. PubMed ID: 2087837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic immunotherapy with topical dinitrochlorobenzene as additional treatment of alopecia areata.
    Yoshizawa Y; Izaki S; Kitamura K; Kawana S
    Acta Derm Venereol; 2002; 82(2):136-8. PubMed ID: 12125944
    [No Abstract]   [Full Text] [Related]  

  • 46. [Alopecia areata and treatment with the diethylester of squaric acid. Behavior of lymphocyte subpopulations].
    Pigatto PD; Gini R; Altomare GF
    G Ital Dermatol Venereol; 1985; 120(3):227-30. PubMed ID: 4030021
    [No Abstract]   [Full Text] [Related]  

  • 47. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alopecia areata: topical immunotherapy--application and practical problems.
    MacDonald N; Wiseman MC; Shapiro J
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
    [No Abstract]   [Full Text] [Related]  

  • 49. Squaric acid dibutylester: indications for use and efficacy in alopecia areata.
    Pardasani AG; Turner E; McMichael AJ
    Arch Dermatol; 2001 Jul; 137(7):970-2. PubMed ID: 11453831
    [No Abstract]   [Full Text] [Related]  

  • 50. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.
    Zöller M; Freyschmidt-Paul P; Vitacolonna M; McElwee KJ; Hummel S; Hoffmann R
    Clin Exp Immunol; 2004 Mar; 135(3):398-408. PubMed ID: 15008971
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diphenylcyclopropenone immunotherapy in ophiasis.
    Singh G; Okade R; Naik C; Dayanand CD
    Indian J Dermatol Venereol Leprol; 2007; 73(6):432-3. PubMed ID: 18032873
    [No Abstract]   [Full Text] [Related]  

  • 53. The therapeutic use of topical contact sensitizers in benign dermatoses.
    Buckley DA; Du Vivier AW
    Br J Dermatol; 2001 Sep; 145(3):385-405. PubMed ID: 11531828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Squaric acid esters in the treatment of alopecia areata.
    Barth JH; Darley CR; Gibson JR
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):846. PubMed ID: 3711389
    [No Abstract]   [Full Text] [Related]  

  • 55. Squaric acid sensitization is not required for response in the treatment of alopecia areata.
    Vedak P; Kroshinsky D
    J Am Acad Dermatol; 2015 Sep; 73(3):471-6. PubMed ID: 26282797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Perret CM; Happle R
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):253-7. PubMed ID: 2007671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Squaric acid dibutylester in alopecia areata: is discomfort really necessary?
    Orecchia G; Rabbiosi G
    J Am Acad Dermatol; 1987 Apr; 16(4):876. PubMed ID: 3571551
    [No Abstract]   [Full Text] [Related]  

  • 58. [Topical therapy of alopecia areata with squaric acid dibutyl ester].
    Morishita M; Nagai T; Sato Y
    Nihon Hifuka Gakkai Zasshi; 1987 Jan; 97(1):61-4. PubMed ID: 3573366
    [No Abstract]   [Full Text] [Related]  

  • 59. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Photochemotherapy plus squaric acid dibutylester in alopecia areata treatment.
    Orecchia G; Perfetti L; Borroni G; Rabbiosi G
    Dermatologica; 1990; 181(2):167-9. PubMed ID: 2242789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.